Search for: "Cephalon Inc." Results 61 - 80 of 169
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Nov 2011, 9:40 pm by Patent Docs
Cephalon Inc. et al. v. [read post]
11 Nov 2011, 2:00 am by Jack Pringle
Cephalon, Inc., Plaintiffs in a putative class action alleging violations of the Sherman Antitrust Act sought to compel discovery of certain communications between Defendant Barr Laboratories, Inc. [read post]
6 Nov 2011, 9:18 pm by Patent Docs
Cephalon Inc. et al. v. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
6 Aug 2011, 12:18 am by Apeng
 (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc, Cephalon France SAS and Cephalon (UK) Ltd v Orchid Europe Ltd and Generics (UK) Ltd (t/a Mylan) / ???? [read post]
3 Aug 2011, 3:31 am by Marie Louise
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon… [read post]
20 Jul 2011, 4:04 am by Marie Louise
(Spicy IP) US: Multicell Technologies receives stem cell patent (Patent Docs) US: FDA’s NDI guidance and the 18-year cycle of correcting regulatory overreach (FDA Law Blog)   Products Adenoscan (Adenosine) – US: Astellas settles Adenoscan patent suit with Sagent and Strides Arcolab (Patent Docs) Angiomax (Bivalirudin) – US: The MDCO PTE decision: In play on Capitol Hill and in action at the PTO (FDA Law Blog) Cipralex (Escitalopram) – Austria: SPCs and Escitalopram in… [read post]
18 Jul 2011, 5:16 pm by FDABlog HPM
(“Cephalon”) on March 15, 2011 challenging FDA’s January 7, 2011 approval of Watson Laboratories, Inc. [read post]
27 Jun 2011, 2:18 am by sally
Court of Appeal (Criminal Division) Manchester Police, R (On the Application Of) v Hookway & Anor [2011] EWHC 1578 (Admin) (19 May 2011) Attorney General v Fraill & Anor [2011] EWCA Crim 1570 (16 June 2011) Court of Appeal (Civil Division) Zinda v Bank of Scotland Plc [2011] EWCA Civ 706 (23 June 2011) High Court (Chancery Division) Chemistree Homecare Ltd & Ors v Roche Products Ltd [2011] EWHC 1579 (Ch) (16 June 2011) Cowderoy v Cranfield [2011] EWHC 1616 (Ch) (24 June 2011) High… [read post]
6 May 2011, 3:00 am by Tom Huddleston Jr.
Fox and Symons led Kirkland's team advising Teva Pharmaceuticals on its $6.8 billion acquisition of Cephalon, Inc. [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
9 Mar 2011, 3:00 am by Marie Louise
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]